Redmile Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.3M | Sell |
|
|||||
|
2025
Q1 | $38M | Sell |
|
|||||
|
2024
Q4 | $34.4M | Sell |
|
|||||
|
2024
Q3 | $39.8M | Sell |
|
|||||
|
2024
Q2 | $37.9M | Sell |
|
|||||
|
2024
Q1 | $47M | Buy |
|
|||||
|
2023
Q4 | $25.9M | Sell |
|
|||||
|
2023
Q3 | $89.5M | Sell |
|
|||||
|
2023
Q2 | $84.6M | Sell |
|
|||||
|
2023
Q1 | $78.2M | Sell |
|
|||||
|
2022
Q4 | $144M | Buy |
|
|||||
|
2022
Q3 | $54.2M | Buy |
|
|||||
|
2022
Q2 | $15M | Sell |
|
|||||
|
2022
Q1 | $22.7M | Hold |
|
|||||
|
2021
Q4 | $33.9M | Sell |
|
|||||
|
2021
Q3 | $60.1M | Sell |
|
|||||
|
2021
Q2 | $69.6M | Buy |
|
|||||
|
2021
Q1 | $72.9M | Buy |
|
|||||
|
2020
Q4 | $59.9M | Sell |
|
|||||
|
2020
Q3 | $71.9M | Buy |
|
|||||
|
2020
Q2 | $9.77M | Sell |
|
|||||
|
2020
Q1 | $12.1M | Sell |
|
|||||
|
2019
Q4 | $25.8M | Sell |
|
|||||
|
2019
Q3 | $26.5M | Sell |
|
|||||
|
2019
Q2 | $22.4M | Buy |
|